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The outcome measures in rheumatology clinical trials (OMERACT) scores are the most mature quan-
titation system for rheumatoid arthritis (RA) on magnetic resonance imaging (MRI).  Direct measuring 
techniques of synovial volume have been reported with good reproducibility,  although few reports 
have demonstrated the changes of these measures in response to treatment.  To assess these clinical 
responses,  we evaluated the correlation of the changes of clinical activity score 28-joints disease activ-
ity score (DAS28-CRP) with the changes of OMERACT scores and with synovial volume measure-
ments.  Eight RA patients who were treated by biologic agents were examined with MRI of the domi-
nant aﬀected wrist and ﬁnger joints before and one year after the treatment.  The total OMERACT 
score was reduced from 48.0 to 41.3,  and synovial volume was reduced from 15.4 to 8.8 milliliters.  
Positive correlations were seen between the changes of DAS28-CRP and the changes of OMERACT 
synovitis score (r＝0.27),  OMERACT total score (r＝0.43) and synovial volume (r＝0.30).  Limited to 
synovium assessment,  synovial volume showed a better correlation with DAS28-CRP than the 
OMERACT synovitis score.  On the other hand,  the OMERACT total score showed a higher correla-
tion with DAS28-CRP than synovial volume,  probably because the OMERACT total score includes 
scores for bone erosion and bone edema as well.
Key words: magnetic resonance imaging,  rheumatoid arthritis,  outcome measures in rheumatology clinical 
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reatments for rheumatoid arthritis (RA) have 
changed remarkably since the advent of biologic 
agents,  and the treatment goals have greatly shifted to 
the achievement of remission and prevention of joint 
destruction.  To evaluate treatment responses,  imag-
ing studies are important in addition to clinical evalu-
ations such as the 28-joints disease activity score 
(DAS28).  Magnetic resonance imaging (MRI) allows 
the assessment of not only bone erosions but also bone 
marrow edema and synovitis,  which are diﬃcult to 
detect on plain radiographic images.
　 The outcome measures in rheumatology clinical 
trials (OMERACT) RA MRI scoring (RAMRIS) scor-
ing system was devised for use in multi-center studies 
as a method of MRI assessment of the wrist and meta-
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carpophalangeal (MCP) joints [1].  It is utilized in 
various clinical studies worldwide as a standard 
assessment method for MRI.  It characteristically 
allows separate scoring of synovitis,  bone erosions,  
and bone marrow edema.  However,  as a total of 53 
sites―7 for synovitis and 23 each for bone erosion 
and bone marrow edema―are evaluated,  its applica-
tion is time-consuming.  In addition,  low reproduc-
ibility has been recognized as a limitation [2].  
Atlases have been published to improve the reproduc-
ibility of results obtained with this method,  [3,  4].  
Nevertheless,  even a trained rater needs about 30min 
to complete the evaluation,  making it diﬃcult to utilize 
in clinical practice.
　 Many studies have demonstrated the use of direct 
measurement of synovial volume and shown its repro-
ducibility.  First,  a manual outlining technique was 
developed,  but outlining the synovitis manually can 
take 1-2h per scan [5,  6].  To reduce analysis times,  
a semi-automated volume measuring system was devel-
oped.  Thresholding in combination with rough manual 
outlining in each plane can substantially reduce analy-
sis times.
　 These studies have reported good reproducibility,  
but did not elucidate patientsʼ responses to treatments.  
In the current study,  we developed thresholding in 
combination with manual outlining in 3D space using a 
medical workstation,  and used it to calculate the syn-
ovial volume.  To assess the eﬀects of biologic treat-
ments,  we evaluated the correlation of the changes of 
clinical activity score (DAS28-CRP) with the changes 
of OMERACT scores and synovial volume.
Patients and Methods
　 Patients and clinical assessments. This 
research was a retrospective single center study con-
ducted between the dates of January 2008 and 
December 2013.  Inclusion criteria included patients 
with rheumatoid arthritis,  biological therapy,  and 
high-ﬁeld (1.5-T) MR imaging examinations at baseline 
and 12 months following the biological therapy.  Of 
the 24 patients undergoing MR imaging before bio-
logic therapy,  16 patients either dropped out of 
therapy or did not undergo MR imaging at the one-
year point.  Thus,  8 patients (7 women and 1 man) 
were included in this study.  Clinical assessment was 
also performed before and 1 year after the initiation 
of treatment with biological agents.  For clinical 
assessment,  the results of the visual analogue scale 
(VAS) for general health,  counts of swollen and ten-
der joints,  and levels of C-reactive protein (CRP) and 
matrix metalloproteinase 3 (MMP-3) were determined.  
DAS28-CRP was calculated from the results obtained.  
The study protocol was approved by the Human Ethics 
Review Committee of Okayama University Hospital.
　 MRI examination and its protocol. MRI 
examinations of the more severely-aﬀected-side wrist,  
MCP and PIP joints were performed at baseline and 
at 1 year.  MRI examinations were performed on a 
1.5-T imaging unit (MAGNETOM Avanto,  ©Siemens,  
Erlangen,  Germany),  utilizing a small ﬂex coil posi-
tioned on the dorsum of the wrist.  Patients were 
examined in the prone position with the arm extended 
and wrist placed in an 8-channel surface-array-coil.  
The imaging sequence was selected based on the 
OMERACT core set recommendation [7].  MR images 
with and without contrast material were acquired;  
T1-weighted spin-echo (TR 641 ms,  TE 11 ms) images,  
short-time inversion recovery (STIR; TR 3070 ms,  
TE 91 ms,  T1 160 ms) images and contrast-enhanced 
(3D gradient recalled echo) images were obtained.  
A bolus of gadolinium (Gd) contrast agent at 
0.1mmol/kg body weight was intravenously injected 
and images were obtained within 10min after injection.
　 Evaluation of MRI ﬁndings. Semiquantita-
tive scoring of synovitis,  bone marrow edema,  and 
bone erosion,  as visualized by MRI,  was performed 
using the European League Against Rheumatism 
(EULAR)-OMERACT RAMRIS scoring system [8].
　 Synovial volumes were measured at the wrist and 
from the 2nd to 5th MCP joints (a total of 5 sites per 
patient) on Gd-3D images.  The volumes were deter-
mined according to the method of Tam et al.  [9],  and 
the enhancement threshold level was set at ＋2.5 
standard deviations (SDs) of the mean intensity of the 
thenar muscle on enhanced images (Fig.  1).  Based on 
the threshold level,  an enhanced area was automati-
cally extracted and a 3D image was constructed.  Next,  
the vascular area was erased manually from the 3D 
image to obtain a semi-automatically measured synovial 
volume with high accuracy.  Volume measurements 
were made using the 3D volumetry function of the 
AZE Virtual Place (AZE Co.,  Tokyo,  Japan) soft-
ware application (Fig.  2).
　 One investigator,  blinded to the patientsʼ proﬁles 
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and the chronological order in which the images had 
been obtained,  assessed all images.
　 To compare the predictability of various MR 
images for clinical scores,  correlations of the DAS28-
CRP results with total and synovitis scores of the 
OMERACT RAMRIS and synovial volumes were 
evaluated.
　 The correlation between the synovitis score of the 
OMERACT RAMRIS and the synovial volume was 
also analyzed in the wrists and the 2nd to 5th MCP 
joints.
　 Statistical analysis. Variables are presented 
as means ± SDs.  The Paired t test was used to 
compare results at baseline and 1 year.  The Pearson 
product-moment correlation coeﬃcient was used.  P 
values ＜0.05 were considered to indicate statistically 
signiﬁcant diﬀerences.
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Fig. 2　 Semi-automatically measurement on a medical workstation.  (A) After thresholding,  the synovial area and vascular area were 
visualized automatically in 3D space.  (B) In 3D space,  the vascular area was manually erased,  and the synovial volume was calculated.
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Fig. 1　 Enhancement threshold.  The enhancement threshold level was set at ＋2.5 standard deviations (SDs) of the mean intensity of 
the thenar muscle on enhanced images.
Results
　 Patient demographics. The mean age was 
58.6±6.4 years and the mean disease duration was 
10±8.1 years.  The biological agents used were inf-
liximab (n＝3),  etanercept (n＝3),  and adalimumab 
(n＝2).  The disease modiﬁed anti-rheumatic-drugs 
(DMARDs) used were salazosulfapyridine (SASP;  
n＝3),  bucillamine (BUC; n＝2),  and tacrolimus 
(TAC; n＝1).  The mean weekly dose of methotrexate 
was 6.5mg.  The mean weekly dose of prednisolone 
was 3.1mg (Table 1).
　 Clinical assessment. Clinical parameters pre- 
and post-treatment are shown in Table 1.  Symptom 
improvements were seen in all 8 patients.  The follow-
ing reductions in clinical parameters were obtained:  
the swollen joint count,  from 4.75 to 1.75; the tender 
joint count,  from 4.50 to 1.13; the VAS score,  from 
41.8 to 16.3; the CRP level (mg/l),  from 2.51 to 
0.22; DAS28-CRP,  from 3.75 to 1.92.
　 MR imaging assessment. The OMERACT 
RAMRIS synovitis,  bone marrow edema,  and bone 
erosion scores changed from 12.1 to 6.6,  from 6.8 to 
4.4,  and from 29.0 to 30.2,  respectively.  The synovial 
volume was reduced from 15.4±7.4ml to 8.8±6.3ml 
(Table 2).  It took 30 to 40min per patient to complete 
scoring by the OMERACT system while approxi-
mately 20min were required to measure the synovial 
volume.
　 Correlation. Changes in synovial volume and 
DAS28-CRP are shown in Fig.  3.  Changes in the 
OMERACT RAMRIS score and DAS28-CRP are 
shown in Fig.  4.  Positive correlations were seen 
between the DAS28-CRP and the OMERACT synovi-
tis score (r＝0.67),  OMERACT total score (r＝0.37) 
and synovial volume (r＝0.66).  The changes in the 
OMERACT RAMRIS total score (r＝0.43),  
OMERACT RAMRIS synovitis score (r＝0.27),  and 
synovial volume (r＝0.30) showed positive correla-
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Fig. 3　 Changes in volume and DAS28-CRP.  Plot of changes in 
synovial volume and DAS28-CRP.
Table 1　 Patientsʼ background
Characteristics Baseline
Age (years) 58.6±6.4
Gender F7,  M1
Disease duration (years) 10±8.1
Biologic agents INF 3,  ETN 3,  ADA 2
DMARDs SASP 3,  BUC 2,  TAC 1
Methotrexate (mg/week) 6.5±2.0
Prednisolone (mg/day) 3.1±1.7
ENT,  etanercept; IFX,  inﬂiximab; ADA,  adalimumab; SASP,  sul-
fasalazine; BUC,  bucillamine; TAC,  tacrolimus.
Table 2　 Changes of clinical parameters
Baseline 1 year
DAS28-CRP 3.7±0.8 1.9±0.5＊
Synovial volume (ml) 15.4±7.4 8.8±6.3＊
OMERACT RAMRIS 48.0±33.8 41.3±36.3＊
　synovitis score 12.1±5.3 6.6±5.3＊
　edema score 6.9±6.9 4.4±6.1
　erosion score 29.0±27.7 30.3±27.8
DAS,  disease activity score; paired t test ＜0.05.
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Fig. 4　 Changes in OMERACT RAMRIS score and DAS28-CRP.  
Plot of changes in OMERACT RAMRIS score and DAS28-CRP.
tions with DAS28-CRP changes (Fig.  5).
　 Correlations between the synovial volume of each 
joint and the OMERACT RAMRIS synovitis score are 
presented in Fig.  6.  In each joint,  synovial volume 
showed a good correlation (r＝0.876) with the 
OMERACT RAMRIS synovitis score.
Discussion
　 The OMERACT RAMRIS system has been used in 
many clinical studies because the results correlate 
with clinical scores of disease activity such as DAS28 
and it is useful for evaluating drug eﬃcacy.  Although 
the OMERACT RAMRIS total score is usually used,  
the synovitis score,  bone marrow edema score,  or 
bone erosion score alone reportedly correlates with 
clinical assessment parameters.  The synovitis and 
bone marrow edema score reportedly correlate with 
the degree of inﬂammation on scintigraphic images as 
well as with levels of CRP and the erythrocyte sedi-
mentation rate (ESR) [10].  Several studies have 
demonstrated that bone erosion,  bone marrow edema,  
or the synovitis score alone predicts the progression 
of bone erosion [11,  12].
　 As the OMERACT RAMRIS system has limita-
tions associated with low reproducibility and its time-
consuming nature,  synovial volumes were measured in 
the present study to determine whether this method 
provides better reproducibility as well as reduced 
reading time.  Measurement of synovial volumes has 
advantages over the RAMRIS score not only in reduc-
ing reading time and enhancing reproducibility but also 
in improving the ability to assess clinical disease 
activity.  Synovial volumes are reportedly useful for 
evaluating treatment eﬃcacy because they correlate 
not only with clinical scores [9,  13] but also with 
changes in clinical scores from pretreatment values 
[14].  They have also been reported to correlate with 
histological inﬂammation [15] and bone erosion pro-
gression [16].
　 Unlike computed tomography (CT) images,  MRI is 
frequently aﬀected by inherent imaging distortions and 
unevenness.  Therefore,  manual outlining is regarded 
as the area selection method yielding the highest 
reproducibility.  However,  a higher-ﬁeld MR scanner 
has become available and extremity coils have been 
developed,  the resolution has improved and distortion 
has decreased.  In recent years,  it has been possible 
to set an enhancement threshold level in order to 
extract an enhanced area,  thereby allowing diﬀeren-
tiation of the synovial area from the vascular area.  
This semi-automated measurement method has been 
widely used.  Because MRI can be obtained with thin 
slices,  and as many as 90 images are obtained during 
one 3D imaging session,  manual outlining has become 
time-consuming and cumbersome to perform.
　 It is challenging to set an enhancement threshold 
level for extracting an enhanced area.  Several studies 
have proposed determining this threshold relative to 
muscle tissue [9,  17] or employing dynamic contrast-
enhanced intensities [9].  In the present study,  dynamic 
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Fig. 5　 Correlation with change of DAS28-CRP.  The changes in 
the OMERACT RAMRIS total score (r＝0.43),  OMERACT RAMRIS 
synovitis score (r＝0.27),  and synovial volume (r＝0.30) showed 
positive correlations with DAS28-CRP changes.
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Fig. 6　 Volume of each joint and OMERACT RAMRIS synovitis 
score.  The synovial volume of each joint and the OMERACT 
RAMRIS synovitis score showed a good correlation (r＝0.88).
MRI was not performed in all 8 patients and the 
threshold level for extracting an enhanced area was set 
relative to the enhancement of muscle tissue (＋2.5 
SDs of the mean thenar muscle enhancement).  In addi-
tion to the intra-articular synovium,  an enhanced area 
contains blood vessels,  tenosynovitis,  and bone mar-
row edema,  all of which must be erased.  This proce-
dure is performed only manually,  and is therefore 
referred to as a semi-automated measurement.  Although 
the blood vessels,  edema,  and tenosynovitis have thus 
far been erased manually on a one-by-one basis,  at 
present a medical workstation for 3D analysis of CT 
images would allow 3D reconstruction of the extracted 
images and detection of the synovium in the 3D space,  
resulting in improved accuracy of extraction and a 
reduction in reading time.  With these measures,  
nearly 15min were required to measure synovial vol-
umes in each of the patients in this study.
　 Since distinguishing synovial ﬂuid from synovial 
tissue is diﬃcult with non-contrast MR imaging,  
administration of contrast medium is necessary for 
measurement of synovial volumes.  Synovial volumes 
measured using unenhanced images are reportedly 
larger than those measured from enhanced images 
[18].  Thus,  administration of contrast material is 
considered to be useful for accurate volume measure-
ment.  The timing of administration of the medium is 
also important.  In one study,  MR images of the knee 
were acquired every 1.75min after administration of 
contrast material.  After 11min,  the boundary between 
the synovial tissue and ﬂuid reportedly became 
obscure [19].  Thus,  the present study protocol 
speciﬁed that 3D images were to be taken within 
10min after injection of contrast medium.
　 Since the OMERACT RAMRIS synovitis score in 
each joint correlated strongly with synovial volume,  
measurement of synovial volumes is considered to be 
useful for clinically assessing the disease state.  The 
change in synovial volume from pretreatment levels 
correlated with the change in DAS28-CRP,  and the 
correlation coeﬃcient was higher than that of the 
change in the OMERACT RAMRIS synovitis score 
but lower than that of the change in the OMERACT 
RAMRIS total score.  Even though we assessed only 
8 subjects in this study,  the present results might 
suggest that synovial volume was more useful for the 
evaluation of treatment response than the OMERACT 
RAMRIS synovitis score alone; however,  it was 
inferior to the OMERACT RAMRIS total score,  
which includes scores for bone erosion and bone mar-
row edema.
　 There were several limitations in this study: (i) the 
sample size was small,  which may have limited the 
statistical power; (ii) all patients had high disease 
activity at baseline and all patients clinically responded 
to therapy,  so low-disease-activity patients and poor 
responders to therapy were not evaluated.
　 In conclusion,  measurement of synovial volumes 
showed higher reproducibility,  reduced reading time 
and a better correlation with DAS28-CRP than the 
OMERACT RAMRIS synovitis score.  However,  this 
method can be said to be less accurate than the 
OMERACT RAMRIS total score at evaluating clinical 
disease activity because the correlations with clinical 
parameters were poorer than those with the 
OMERACT RAMRIS total score.
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